Skip to content

At-home ketamine vs in-clinic treatment

How telehealth ketamine programs work, how they compare with infusions and Spravato on evidence, safety, cost and coverage, and questions to ask.

Updated · Checked by the Covered Mind editorial team against cited sources

Key facts

  • Last checked:
  • Sources listed: 1
  • Reading time: About 2 minutes
  • At-home programs: typically run four to eight sessions over a month
  • In-clinic cost per session: $350 to $850
  • Spravato cost per session: $10 to $250 insured
  • Spravato dose: Fixed 56 or 84 mg
Key facts
FactValue
Last checked
Sources listed1
Reading timeAbout 2 minutes
At-home programstypically run four to eight sessions over a month
In-clinic cost per session$350 to $850
Spravato cost per session$10 to $250 insured
Spravato doseFixed 56 or 84 mg

What at-home programs are

A telehealth company screens you by video, a prescriber orders sublingual ketamine lozenges from a compounding pharmacy, and you take them at home on a schedule, usually with a video check-in or a companion present and an app for mood tracking. Programs typically run four to eight sessions over a month, plus a pharmacy fee. Check your plan in the coverage checker and read ketamine coverage by insurer. For the session schedule and common questions in one place, see the ketamine therapy overview.

What happens during in-clinic treatment?

IV or IM ketamine given by a clinician with blood pressure monitoring and a recovery period, or Spravato (esketamine) at a certified center with two hours of mandated observation.

Read Ketamine therapy for depression.

Comparison

Comparison table
At-home lozengesIn-clinic ketamineSpravato
EvidenceSmall, mostly observationalMultiple controlled trials (IV)Large FDA trials
Dose controlVariable absorption, self-administeredPrecise, adjustableFixed 56 or 84 mg
MonitoringVideo or noneVitals, clinician presentMandated 2 hours
Cost per sessionVaries, plus pharmacy$350 to $850$10 to $250 insured
InsuranceNoRarelyYes, with prior authorization
Misuse riskHigher (supply at home)LowLow

What has the FDA said about compounded ketamine?

The FDA has warned that compounded ketamine, including oral formulations, is not approved for any psychiatric condition and that at-home use without monitoring carries risks including sedation, dissociation, blood pressure changes and misuse. It has not prohibited the practice.

For the effects clinicians watch for during and after a dose, read Side effects and safety: Spravato, ketamine and TMS.

Who chooses what

At-home programs appeal to people far from clinics, on tight budgets, or unable to arrange rides and time off. In-clinic treatment suits people who want measured dosing and a clinician present, or who have blood pressure or cardiac history. Spravato suits people with insurance that covers it and a history that meets its criteria. Compare dose, monitoring and cost in IV ketamine vs at-home ketamine.

What should you ask an at-home ketamine program?

  • Who is the prescriber and how often do they see you?
  • What happens if you feel unwell during a session?
  • How is the lozenge dose chosen and adjusted?
  • What is the total cost including pharmacy?
  • What is the plan after the initial course?

If you are weighing an in-clinic option, bring Questions to ask a Spravato, ketamine or TMS clinic to the consult.

See ketamine therapy for clinics near you, many of which offer both in-clinic and hybrid options.

Related reading: Ketamine therapy: the complete guide and Driving and monitoring rules for Spravato and ketamine.

Checked by the Covered Mind editorial team · · Editorial policy

Cite this

Covered Mind. "At-home ketamine vs in-clinic treatment." https://www.coveredmind.com/guides/at-home-ketamine-vs-in-clinic. Last checked Sep 1, 2026.

This site provides general information about insurance coverage and treatment options. It is not medical advice, not a guarantee of coverage, and not a substitute for talking with a clinician or your health plan.